300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Oil and Gas
Retail
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Recruiting
Sporting Goods
Manufacturing
FinTech
Web3
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Medical
Internet
Mobile Advertising
Theatre
Android
Proptech
Impact
Sustainability
Enterprise
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 25 Medical VC Funds & Investors in Norway (October 2026)

The most active venture capital funds investing in Norway Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Norway Medical startup companies. Find investors to raise a Series A, Series B or Venture - Series Unknown round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Birk Venture
VC Fund
4 Norway, United Kingdom Seed, Series A Biotechnology, Medical, Health Care $1.2M–$20M
M Ventures
VC Fund
2 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Farvatn Venture
VC Fund
2 Norway, United States, United Kingdom Seed, Pre-Seed Software, Artificial Intelligence, Health Care $120k–$8M
Canica
VC Fund
2 Norway, Denmark, Singapore Series A, Private Equity, Venture - Series Unknown Biotechnology, Beauty, Retail $2.1M–$29M
Investinor
VC Fund
2 Norway, United States, Sweden Venture - Series Unknown, Series A Software, Biotechnology, Manufacturing $2M–$25M
Sandwater
VC Fund
2 Norway, Germany, Finland Series A, Venture - Series Unknown, Series B Manufacturing, Medical, AgTech $4.7M–$35M
Hadean Ventures
VC Fund
2 Sweden, Norway, Austria Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2M–$79M
TeleVenture Management
VC Fund
1 Norway, United States Venture - Series Unknown, Seed Software, Manufacturing, Biotechnology $686k–$5.9M
Sofinnova Partners
VC Fund
1 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Arkin Bio Ventures
VC Fund
1 United States, Israel, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $11M–$182M
4BIO Capital
VC Fund
1 United States, United Kingdom, France Series A, Seed, Series B Biotechnology, Health Care, Therapeutics $5M–$125M
Advent Life Sciences
VC Fund
1 United States, United Kingdom, France Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $5.5M–$104M
Advent Venture Partners
VC Fund
1 United Kingdom, United States, Switzerland Series B, Series A Biotechnology, Health Care, Software $6.6M–$50M
Bioqube Ventures
VC Fund
1 United States, France, Norway Seed, Series A, Series B Biotechnology, Therapeutics, Life Science $4M–$108M
Swiss Diabetes Venture Fund
VC Fund
1 United States, Norway, Sweden Series A, Venture - Series Unknown Health Care, Medical Device, Medical $6.6M–$25M
Nordic Angel Program
VC Fund
1 Norway, Estonia, Finland Seed, Angel Apps, Software, Productivity Tools $70k–$1M
SHS Capital
VC Fund
1 Germany, Switzerland, France Venture - Series Unknown, Series B Health Care, Medical Device, Medical $5.3M–$60M
Innovestor
VC Fund
1 Finland, Sweden, Denmark Seed, Venture - Series Unknown, Pre-Seed Software, Health Care, Information Technology $204k–$5.1M
Stenshagen Invest
VC Fund
1 Norway Venture - Series Unknown, Series C Grocery, Medical, Chemical $18M–$21M
Andenes Investments
VC Fund
1 Norway, United Kingdom Series A, Venture - Series Unknown Mobile, FinTech, Medical
Project Sandwater
VC Fund
1 Norway, The Netherlands Series A Medical, Consulting, Life Science $12M–$20M
HealthCap
VC Fund
1 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $6M–$92M
Surveyor Capital
VC Fund
1 United States, China, Canada Series B, Post-IPO Equity, Series C Biotechnology, Health Care, Therapeutics $41M–$280M
SR One
VC Fund
1 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6M–$175M
Yabeo
VC Fund
1 Germany, United States, United Kingdom Series A, Seed, Series B Software, Financial Services, FinTech $2M–$29M
Access all 44 VC funds in Norway Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Birk Venture
VC Fund · Oslo, Oslo, Norway · 4 investments in Norway Medical startups

Birk Venture is a Scandinavian venture company exclusively focusing on the life science industry.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: Norway, United Kingdom

Investor stats

  • Total investments: 9
  • Round size: Seed $1.3M–$15M; Series A $1.2M–$20M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • APIM Therapeutics — APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellularresponses to DNA damage and stress.
  • Zelluna Immunotherapy — Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.
  • Accession Therapeutics — Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity. It is the first company to have engineered a viral point of entry to cancer cells while bypassing healthy cells - so it’s ‘gloves off’ in the fight against cancer." It was founded in 2020 and is locatedin Oxford, Oxfordshire, United Kingdom.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Norway Medical startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 188
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
  • Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
Show all investments...

Farvatn Venture
VC Fund · 2 investments in Norway Medical startups

Planet 9 Venture supports startups and work with venture funds to make a positive imprint on the world.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: Norway, United States, United Kingdom

Investor stats

  • Total investments: 85
  • Round size: Seed $1M–$8M; Pre-Seed $120k–$1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Visoid — Render your 3D models with ease! Quick and easy rendering software for architects, powered by AI. Try Visoid for free!
  • BioSort — Biometrics provides lice, biomass, extraction, and data analysis. They offer feed, fish health, welfare, optimized harvest aquaculture, and fisheries. They provide sensor technologies, machine vision, AI, software, mechatronics.
  • Birdsview — Sensor fusion of GPR radar, lidar and camera plus AI analysis: see inside any concrete structure without breaking it.
Show all investments...

Canica
VC Fund · Oslo, Oslo, Norway · 2 investments in Norway Medical startups

Canica is one of the largest privately owned investment companies in Norway. Our operations are focused on active, long-term ownership, primarily within sectors covering retail, fast moving consumer goods and real estate. Canica can offer core expertise within the fields of business development and finance, as well as capital and network in orderto create value and employment in a long-term perspective.

Show more...

Investment focus

  • Industry: Biotechnology, Beauty, Retail
  • Stage:Series A, Private Equity, Venture - Series Unknown
  • Geography: Norway, Denmark, Singapore

Investor stats

  • Total investments: 16
  • Round size: Series A $2.1M–$25M; Venture - Series Unknown $20M–$29M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Healthily — The path to perfect health starts with self-care and Healthily is here to guide you step by step.
  • Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
  • Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
Show all investments...

Investinor
VC Fund · Trondheim, Sor-Trondelag, Norway · 2 investments in Norway Medical startups

Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Venture - Series Unknown, Series A
  • Geography: Norway, United States, Sweden

Investor stats

  • Total investments: 132
  • Round size: Series A $2.3M–$25M; Venture - Series Unknown $2M–$19M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — raised $274M in 2011

Portfolio highlights

  • Sonair — Make your robot safe, affordable, and efficient with the Sonair 3D ultrasonic sensor.
  • Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
  • Muybridge — Reimagining cameras with weightless software-based viewpoint
Show all investments...

Sandwater
VC Fund · Oslo, Oslo, Norway · 2 investments in Norway Medical startups

We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, AgTech
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Norway, Germany, Finland

Investor stats

  • Total investments: 24
  • Round size: Series A $8.5M–$24M; Series B $17M–$35M; Venture - Series Unknown $4.7M–$18M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Mantle8 — Using bottom-up exploration and decades of geology experience, we are on a mission to deliver natural hydrogen to the world.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
  • Alva Industries — Serving industries from aerospace to marine, we deliver high-performance, sustainable motors to drive a cleaner, more efficient future.
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 2 investments in Norway Medical startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Sweden, Norway, Austria

Investor stats

  • Total investments: 36
  • Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely still investing — raised $168M in 2021

Portfolio highlights

  • Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

TeleVenture Management
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Medical startups

Making Venture Happen. Televenture is one of the leading venture capital companies in Norway.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Biotechnology
  • Stage:Venture - Series Unknown, Seed
  • Geography: Norway, United States

Investor stats

  • Total investments: 26
  • Round size: Venture - Series Unknown $686k–$5.9M
  • Lead/follow: 65% lead, 35% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • CrayoNano — CrayoNano is a next generation semiconductor company. We specialize in nanotechnology that will enable a more sustainable and healthier life for tomorrow.
  • Genetic Analysis — Genetic Analysis AS (GA) has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances. By utilizing the DNA-based GA-map™ array technology, profiles of a patient’s gut microbiota is quickly generated and can be related to various health conditions. Genetic Analysis has developed a DNA-basedtechnology platform that allows for simultaneous analysis of a large number of similarities (but not identical) gene fragments in one reaction. The company’s focus is to utilize this technology platform to identify variations in the hundreds of different bacteria that exist in the gut (large and small intestine). The GA - map makes it possible, for the first time, to offer a diagnostic solution – including early detection - for many diseases that are affected by imbalances in the gut microbiota. Genetic Analysis will offer kits and services for a wide range of applications.
  • Stingray Marine Solutions — Stingray Marine Solutions is a Norwegian technology firm that produces a laser unit which, when lowered into salmon farming pens, kills sea lice. It is based on entrepreneur Esben Beck’s patented idea in 2010 for salmon louse removal using camera vision and laser. It all started with Esben Beck and a lathe in his basement in 1999. After more than10 years of deliveries to oil, gas and offshore companies, he decided to invest in his own products. He decided to found and develop his own salmon louse project, where design, production, software development, testing, and installation were carried out by using in-house resources.Stingray is based in Oslo, Norway.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Norway Medical startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 353
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
  • EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Show all investments...

Arkin Bio Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 1 investments in Norway Medical startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 24
  • Round size: Series A $11M–$125M; Series B $13M–$80M; Series C $19M–$182M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • Ambros Therapeutics — Ambros Therapeutics is a clinical-stage biotechnology company focused on the development of innovative and transformative medicines for diseases.
  • Reunion Neuroscience — Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions. The Company’s lead asset, RE104, is a proprietary, novel serotonergic psychedelic compound being developed as a potential fast-acting and durable antidepressant for patients suffering from postpartum depressionand other mental health conditions. Reunion is also developing the RE200 series, which includes compounds with the potential for more selective serotonin receptor activity and reduced psychoactivity for application in more chronic treatment paradigms and indications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
4BIO Capital
VC Fund · London, England, United Kingdom · 1 investments in Norway Medical startups

4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs.4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech -biologics, gene and cell therapy and bioinformatics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 35
  • Round size: Seed $5M–$33M; Series A $24M–$94M; Series B $12M–$125M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $10M in 2026

Portfolio highlights

  • ViaNautis — Precision Solutions
  • Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
  • Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 1 investments in Norway Medical startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 73
  • Round size: Series A $5.5M–$51M; Series B $21M–$97M; Venture - Series Unknown $7M–$104M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Advent Venture Partners
VC Fund · London, England, United Kingdom · 1 investments in Norway Medical startups

Advent Venture Partners is one of Europe's most successful growth and venture capital investors in market-leading tech and life sciences businesses. They have designed their strategy, teams and funds so they can focus on backing a select few companies. They pride their selves on establishing true partnerships with entrepreneurs in order tobuild valuable businesses together.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 91
  • Round size: Series A $6.6M–$26M; Series B $7M–$50M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $25M in 2019

Portfolio highlights

  • Wiz — Organizations of all sizes and industries use Wiz to rapidly identify and remove the most critical risks in AWS, Azure, GCP, and Kubernetes so they can build faster and more securely.
  • OpenCloud — Our cloud native software solutions dramatically improve operator business models and help quickly create new revenue-generating services.
  • Acutus Medical — Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists.Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Itsproducts are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.It was founded in 2011 and headquartered in Carlsbad, California.
Show all investments...

Bioqube Ventures
VC Fund · Hasselt, Limburg, Belgium · 1 investments in Norway Medical startups

Bioqube Ventures helps science succeed by turning discoveries into transformative medicines.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States, France, Norway

Investor stats

  • Total investments: 18
  • Round size: Seed $5.7M–$24M; Series A $4M–$76M; Series B $23M–$108M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • Spica Therapeutics — Spica Therapeutics is a biotech company to transform macrophage biology into breakthrough therapies for patients.
  • Primmune Therapeutics — Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
Show all investments...

Swiss Diabetes Venture Fund
VC Fund · Lausanne, Vaud, Switzerland · 1 investments in Norway Medical startups

Swiss Diabetes Venture Fund is europe’s first venture fund dedicated to diabetes technology.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Venture - Series Unknown
  • Geography: United States, Norway, Sweden

Investor stats

  • Total investments: 6
  • Round size: Series A $6.6M–$24M; Venture - Series Unknown $7.6M–$25M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
  • BOYDSense — BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath. The company provides breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using it to diagnose and monitor chronicdiseases.It was founded in 2015 and headquartered in South San Francisco, California.
  • Luna Diabetes — Luna Diabetes offers smart insulin delivery for pen users, designed for safe overnight use so you can wake up rested and in control.
Show all investments...

Nordic Angel Program
VC Fund · 1 investments in Norway Medical startups

International training and investment program for business angels

Show more...

Investment focus

  • Industry: Apps, Software, Productivity Tools
  • Stage:Seed, Angel
  • Geography: Norway, Estonia, Finland

Investor stats

  • Total investments: 5
  • Round size: Seed $354k–$1M; Angel $70k–$134k
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • GlucoSet — GlucoSet develops tools for accurate continuous glucose monitoring in Intensive Care Units, to reduce patient mortality and hospital costs.
  • Fractory — Custom metal fabrication services | Prototyping, project & volume production | 1-1 engineering support, flexible payment terms, instant quotes & lead times.
  • Zelos Team Management — A very simple app for mobile teams. Promoting #volunteering and #selfsignup as a mindset for successful teamwork everywhere.
Show all investments...

SHS Capital
VC Fund · Tübingen, Baden-Wurttemberg, Germany · 1 investments in Norway Medical startups

SHS is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics, and Digital Health sectors.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Venture - Series Unknown, Series B
  • Geography: Germany, Switzerland, France

Investor stats

  • Total investments: 44
  • Round size: Series B $5.3M–$60M; Venture - Series Unknown $6.6M–$21M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: Likely still investing — raised $273M in 2022

Portfolio highlights

  • Arzneimittelwerk Warngau — Unsere Schwerpunkte Karriere bei AMW
  • ROTOP — ROTOP is a pharmaceutical company. They manufacture cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine. They provide API/precursor synthesis, analysis kit development, project management, full regulatory support spect, PET, quality control, and therapy services. Their customers contact throughemail and phone number.
  • Salvia BioElectronics — Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.
Show all investments...

Innovestor
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Norway Medical startups

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 97
  • Round size: Seed $477k–$4.5M; Pre-Seed $204k–$2M; Venture - Series Unknown $529k–$5.1M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: Likely still investing — raised $33M in 2023

Portfolio highlights

  • Khoy — Khoy Company designs and develops comfortable, user-friendly, and sustainable sofa beds.
  • AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
  • Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Show all investments...

Stenshagen Invest
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Medical startups

Stenshagen Invest is an investment firm.

Show more...

Investment focus

  • Industry: Grocery, Medical, Chemical
  • Stage:Venture - Series Unknown, Series C
  • Geography: Norway

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $18M–$21M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
  • Oda — Oda is an online grocery retailer that provides door-to-door delivery services. It offers a huge range of fresh produce groceries to millions of doorsteps. Using the data-driven methodology, with a focus on sustainability all the way along the chain, the company aims to build an efficient retail system in the world. The company was founded in2013 and is headquartered in Oslo, Norway.
  • Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
Show all investments...

Andenes Investments
VC Fund · 1 investments in Norway Medical startups

Andenes Investments

Show more...

Investment focus

  • Industry: Mobile, FinTech, Medical
  • Stage:Series A, Venture - Series Unknown
  • Geography: Norway, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
  • Molo Finance — Molo is the UK's first fully-digital mortgage lender. We're transforming the mortgage experience to make it faster, better and cheaper for our customers. We achieve this by pioneering technology and AI, to ensure real time decision making and instant data validation, eliminating any paperwork, waiting time and hassle. Direct-to-consumerand straight to the point.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Project Sandwater
VC Fund · Oslo, Oslo, Norway · 1 investments in Norway Medical startups

Project Sandwater is a fresh take on venture investments within the Nordics and beyond.

Show more...

Investment focus

  • Industry: Medical, Consulting, Life Science
  • Stage:Series A
  • Geography: Norway, The Netherlands

Investor stats

  • Total investments: 2
  • Round size: Series A $12M–$20M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Delft IMP — Delft IMP (Intensified Materials Production) commercializes nanostructuring of particles using atomic and molecular layer deposition (ALD and MLD), based on the patented and publicized IP and know-how developed within the Product & Process Engineering (PPE) group at Delft University of Technology. Following various feasibility projects betweenindustry and university, Delft IMP was initiated end 2014 to truly commercialize the technology.
  • Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Norway Medical startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 141
  • Round size: Series A $6M–$73M; Series B $12M–$92M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $179M in 2024

Portfolio highlights

  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Surveyor Capital
VC Fund · Chicago, Illinois, United States · 1 investments in Norway Medical startups, 11 in the past 12 months

Surveyor Capital is a fundamental equities business. Surveyor’s sector-aligned investment teams aim to generate alpha through a deep understanding of each company’s strategy, management teams, drivers of performance, and cyclical and secular industry trends over the medium and long term.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Post-IPO Equity, Series C
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 174
  • Round size: Series B $60M–$170M; Series C $60M–$200M; Post-IPO Equity $41M–$280M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Enveda Biosciences — Enveda exists to give hope to millions of people around the world by accelerating the discovery of better medicines.
  • Lisata Therapeutics — Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of innovative medicines.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 1 investments in Norway Medical startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 202
  • Round size: Series A $6M–$100M; Series B $15M–$114M; Series C $22M–$175M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $237M in 2025

Portfolio highlights

  • CalciMedica — CalciMedica is a clinical-stage biopharmaceutical company advancing CRAC channel inhibitors for pulmonary hypertension and acute pancreatitis.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Korsana Biosciences — Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases. The company focuses on shuttled monoclonal antibodies that cross the blood-brain barrier to reach central nervous system targets. Its lead program, KRSA-028, is an investigational anti-amyloid beta antibody for Alzheimer’s disease that uses a transferrinreceptor-based shuttle and Fc engineering to improve brain delivery and dosing. Korsana is also advancing additional THETA-based programs for undisclosed neurodegenerative indications.
Show all investments...

Yabeo
VC Fund · Grünwald, Bayern, Germany · 1 investments in Norway Medical startups

We are an early-stage investor that believes in flexible Evergreen funding without the limitations of traditional funds.

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Series A, Seed, Series B
  • Geography: Germany, United States, United Kingdom

Investor stats

  • Total investments: 46
  • Round size: Seed $2M–$5.1M; Series A $5.2M–$21M; Series B $7M–$29M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Yazen — Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical treatments with lifestyle coaching. The platform connects users with a team of experts, including doctors, dietitians, and personal trainers, to create individualized weight management plans.
  • WithLess — Apps multiply, costs grow, admin spirals. We get it. The tools your team needs WithLess time, money, and admin.
  • norahealth.ai — Leading 3D motion-tracking API that powers digital MSK, health & wellness applications. Automatize motion assessments and track the adherence of your members with our extensive exercise library.
Show all investments...

Medical VC funding in Norway at a glance

Stats across 45 deals from 44 investors.

44
investors
in Norway Medical startups
45
deals
in Norway Medical startups
$2.6M
median round
in Norway Medical startups
64%
lead investors
lead at least one round
27%
Grant
most common funding stage

Access all 44 VC funds in Norway Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Norway investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 44 VC funds investing in Norway Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists